Dr. Gunn, a cardiothoracic surgeon, gained an interest in ECMO during his residency and fellowship during the COVID-19 pandemic.
ECMO is a portable heart-lung machine which deoxygenates blood. Traditionally used as a last resort, the device was effective in treating COVID-19 patients, according to the report.
“In my last year of surgical residency, I worked in a hospital where most of the patients we treated were unvaccinated against COVID-19 and many of them required ECMO for survival,” Dr. Gunn said in the report. “I learned alongside my mentor, who happened to be a co-inventor of ECMO, which further fueled my understanding and interest in its use.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
